Glimeryl Tafla 1 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 1 mg

teva b.v.* - glimepiride - tafla - 1 mg

Glimeryl Tafla 2 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 2 mg

teva b.v.* - glimepiride - tafla - 2 mg

Glimeryl Tafla 3 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 3 mg

teva b.v.* - glimepiride - tafla - 3 mg

Glimeryl Tafla 4 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 4 mg

teva b.v.* - glimepiride - tafla - 4 mg

Tandemact Europeiska unionen - isländska - EMA (European Medicines Agency)

tandemact

cheplapharm arzneimittel gmbh - lyfleysu, glimepiride - sykursýki, tegund 2 - lyf notuð við sykursýki - tandemact er ætlað fyrir sjúklinga með tegund-2 sykursýki sem sýna óþol að kvarta eða fyrir hvern kvarta er ekki ætlað og hver ert nú þegar meðhöndluð með sambland af lyfleysu og glimepiride.

Jalra Europeiska unionen - isländska - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Xiliarx Europeiska unionen - isländska - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Sitagliptin Sandoz Filmuhúðuð tafla 100 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

sitagliptin sandoz filmuhúðuð tafla 100 mg

sandoz a/s* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Sitagliptin Sandoz Filmuhúðuð tafla 50 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

sitagliptin sandoz filmuhúðuð tafla 50 mg

sandoz a/s* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Galvus Europeiska unionen - isländska - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.